
Class Action Lawsuit Filed Against Regeneron Pharmaceuticals, Inc. (REGN) by Pomerantz Law Firm: Investor Information
Class Action Lawsuit Filed Against Regeneron Pharmaceuticals: What Does This Mean for Investors and the World? On February 25, 2025, Pomerantz LLP, a renowned securities litigation law firm, announced the filing of a class action lawsuit against Regeneron Pharmaceuticals, Inc. (Regeneron or the Company) in the United States District Court for the Southern District of…